Press Release
Sparta's E-Waste Recycler ERS Grows Its Carbon Credit Program With Yet Another Crypto Mining Customer
Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws Read More
Press Release
Moderna R&D Day Highlights Progress and Strategic Priorities
Focuses on ten product approvals through 2027 Expects to submit next-generation COVID vaccine for approval in 2024 Expects to submit flu/COVID combination vaccine for approval in 2024 Announces positive Phase 3 results for its RSV vaccine for high-risk adults aged 18 to 59; expects to submit sBLA for U.S. approval in 2024 Announces positive Phase 3 results for its standalone flu vaccine for adults aged 65 and older relative to high-dose licensed comparator Announces norovirus vaccine advances into Phase 3 study, bringing the total of non-respiratory pivotal stage programs to five, across oncology, rare diseases and first-in-class vaccines Implements portfolio prioritization and cost efficiencies to reduce R&D expense by $1.1 billion, from $4.8 billion in 2024E to $3.6-3.8 billion in 2027 Updates and extends financial framework through 2028 Read More
Press Release
International Literacy Association Partners With SmartBrief to Launch ILA Literacy Teaching & Learning SmartBrief
SmartBrief is excited to announce the debut of the ILA Literacy Teaching & Learning SmartBrief, a weekly email newsletter that will deliver the most important and timely news stories for literacy professionals across the globe. Read More
Press Release
HomeAid Affiliates Across the Country Collected and Distributed Over 8.3 Million Diapers and Other Essential Baby and Personal Hygiene Items
HomeAid 's Annual Spring and Summer Essentials Drives Deliver Millions of Critical Baby Items to Children and Families Experiencing or at Risk of Homelessness Read More
Press Release
OS Therapies Announces Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Developed Based on Tunable Antibody Drug Conjugate (tADC) Platform Using Proprietary Silicone Linker Platform in Preclinical Models
Folate receptor alpha targeting drug conjugate & hexa silanol exatecan (FRA-H) payloads tested in animal models of ovarian cancer Strong efficacy for FRA-H in KB and IGROV-1 mouse models of ovarian cancer Strong safety profile for FRA-H with no loss of bodyweight as compared with control in animal models Success of tADC proof-of-concept study paves way for creating multiple potential therapeutic candidates for preclinical and clinical evaluation Read More
Press Release
Nona Scientific Welcomes Industry Veteran Robb Chapin as Chairman of Newly Launched Advisory Board
Chapin will work closely with CEO Mac McKellar to oversee the company's strategic initiatives, bringing his extensive experience in senior living and healthcare investments to the Florida-based lab company. Read More
Press Release
